|Articles|March 1, 2012

Early and Late Adapters of the PCMH

Dr. Chernew asks if organizations that are recognized as a PCMH receive any rewards for such a title. Panelists discuss the difference in motivation between early and later adapters of the PCMH.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Segment 9 - Impact of Healthcare Reform on Cancer Care

By

November 3rd 2016

Segment 8 - Covering the Gaps in Cancer Survivor Care

By

November 3rd 2016

Segment 7 - Successful Discussions on Advance Care Planning and EOL

By

November 3rd 2016

Segment 6 - Reimbursing Value-Based Oncology Care

By

November 3rd 2016

Segment 5 - An Ideal Patient Portal

By

November 3rd 2016

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Early and Late Adapters of the PCMH

Newsletter

Related Content

Segment 9 - Impact of Healthcare Reform on Cancer Care

Segment 8 - Covering the Gaps in Cancer Survivor Care

Segment 7 - Successful Discussions on Advance Care Planning and EOL

Segment 6 - Reimbursing Value-Based Oncology Care

Segment 5 - An Ideal Patient Portal

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD